These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Buprenorphine as maintenance treatment in rehabilitation of heroin addicts]. Bramness JG; Bachs LC; Waal H Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2452-4. PubMed ID: 12448114 [TBL] [Abstract][Full Text] [Related]
46. Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia. Vicknasingam B; Mazlan M; Schottenfeld RS; Chawarski MC Drug Alcohol Depend; 2010 Sep; 111(1-2):44-9. PubMed ID: 20478668 [TBL] [Abstract][Full Text] [Related]
48. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects. De S; Jain R; Ray R; Dhawan A; Varghese ST Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352 [TBL] [Abstract][Full Text] [Related]
49. An injection depot formulation of buprenorphine: extended bio-delivery and effects. Sigmon SC; Moody DE; Nuwayser ES; Bigelow GE Addiction; 2006 Mar; 101(3):420-32. PubMed ID: 16499515 [TBL] [Abstract][Full Text] [Related]
50. A population pharmacokinetic and pharmacodynamic modelling approach to support the clinical development of RBP-6000, a new, subcutaneously injectable, long-acting, sustained-release formulation of buprenorphine, for the treatment of opioid dependence. Nasser AF; Heidbreder C; Gomeni R; Fudala PJ; Zheng B; Greenwald MK Clin Pharmacokinet; 2014 Sep; 53(9):813-24. PubMed ID: 25015174 [TBL] [Abstract][Full Text] [Related]
51. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women. Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361 [TBL] [Abstract][Full Text] [Related]
52. Rapid heroin detoxification using a single high dose of buprenorphine. Kutz I; Reznik V J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266 [TBL] [Abstract][Full Text] [Related]
53. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin. Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843 [TBL] [Abstract][Full Text] [Related]
54. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification. Sobel BF; Sigmon SC; Walsh SL; Johnson RE; Liebson IA; Nuwayser ES; Kerrigan JH; Bigelow GE Drug Alcohol Depend; 2004 Jan; 73(1):11-22. PubMed ID: 14687955 [TBL] [Abstract][Full Text] [Related]